References
- Cines DB, Cuker A, Semple JW. Pathogenesis of immune thrombocytopenia. Presse Med 2014; 43:e49–e59
- Karpatkin S. Autoimmune thrombocytopenias. Autoimmunity 2004;37:363–368
- Louache F, Vainchenker W. Thrombocytopenia in HIV infection. Curr Opin Hematol 1994;1:369–372
- Nardi MA, Tomlinson S, Greco MA, Karpatkin S. Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell 2001;106:551–561
- Nardi MA, Liu LX, Karpatkin S. GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia. Proc Natl Acad Sci USA 1997;94:7589–7594
- Shattil SJ, Ginsberg MH. Integrin signalling in vascular biology. J Clin Invest 1997;100:1–5
- Nardi M, Feinmark SJ, Hu L, Li Z, Karpatkin S. Complement-independent Ab-induced peroxide lysis of platelet requires 12-lipoxygenase and a platelet NADPH oxidase pathway. J Clin Invest 2004;113:973–980
- Li Z, Nardi MA, Karpatkin S. Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia. Blood 2005;106:572–576
- Zhang W, Nardi MA, Borkowsky W, Li Z, Karpatkin S. Role of molecular mimicry of hepatitis C virus protein with platelet GPIIIa in hepatitis C-related immunologic thrombocytopenia. Blood 2009;113:4086–4093
- Zhang W. Platelet fragmentation: A novel opinion for thrombosis therapy. Drug Develop Res 2013;74:553–557